Trademark Attorney / Law Firm

David Shawn Lipkus – Trademark Portfolio

David Shawn Lipkus specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 2 of 3 total filings concentrated in this category. The practice also covers Class 32 (Light Beverages) along with 2 other Nice Classification classes. Filing activity spans from 2023 to 2026. Currently, 0 trademarks are registered and 2 are pending.

3 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

David Shawn Lipkus's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

32
Light Beverages (1 filing)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

Frequently Asked Questions

How many trademark applications has David Shawn Lipkus filed?

David Shawn Lipkus has filed 3 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 2 pending, 1 abandoned.

What trademark classes does David Shawn Lipkus specialize in?

David Shawn Lipkus has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

How long has David Shawn Lipkus been filing trademarks?

David Shawn Lipkus's trademark filing history with the USPTO spans from 2023 to 2026, covering 3 years of trademark practice. During this period, David Shawn Lipkus has handled 3 trademark applications.

What is David Shawn Lipkus's trademark registration success rate?

David Shawn Lipkus has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 2 applications are pending review.